Spectrum Pharmaceuticals, Inc. | TalkMarkets

Latest Posts

The Dream Team Disruptors - Einstein's In Biopharma 2020-2021

Article By: James Gornick

Tuesday, November 24, 2020 7:18 AM EDT

The trends in the final months of 2020 and moving into 2021 have assembled "The Dream-Team" in saving many lives and the losses in functionalities in those infected with COVID-19 World-Wide Pandemic.

In this article: AZN, JNJ, PFE, CYDY, ABIO, REGN, SPPI, MRNA, AXDX, CAPR, MESO, NVS Also: INO, SRNE, NVAX, DVAX, CRSP

Read

Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone

Article By: Benzinga

Friday, December 27, 2019 4:23 PM EDT

B Riley FBR analyst Mayank Mamtani maintained a Buy rating on Spectrum and lowered the price target from $18 to $11.

In this article: SPPI

Read

Week In Review: China Pharmas Announce Deals Worth $1.5 Billion

Article By: ChinaBio® Today

Saturday, December 8, 2018 4:21 PM EDT

WuXi AppTec, China's largest CRO/CMO, completed a $1 billion IPO on the Hong Kong markets, pricing the offering in the middle of the expected range (see story). In May, WuXi became a public company by completing a $328 million IPO in Shanghai.

In this article: RVNC, VBIV, CASI, SPPI

Read

Spectrum (SPPI) Earnings And Sales Beat Estimates In Q1

Article By: Zacks Investment Research

Saturday, May 5, 2018 9:05 PM EDT

Spectrum Pharma’s shares have underperformed the industry so far this year. The stock has lost 16.5% against the industry’s decline of 5%. Plus more news on Amgen, Ligand Pharmaceuticals and Protagonist Therapeutics.

In this article: SPPI, AMGN, LGND, PTGX

Read